Aida Oncology
Copenhagen, Denmark· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Aida Oncology is a Danish precision oncology company founded in 2018 that develops AI-driven diagnostic tools to predict patient response to chemotherapy. Its core technology, OncoTect, analyzes RNA expression from tumor biopsies to generate Drug Sensitivity Scores, aiming to guide more effective, personalized treatment selection. The company is initially focused on improving outcomes in breast cancer.
Diagnostics